MicroPort Scientific Corporation

Equities

853 KYG608371046

Advanced Medical Equipment & Technology

Delayed Hong Kong S.E. Other stock markets 04:06:22 18/07/2024 BST			5-day change	1st Jan Change
5.4 ^HKD	+0.37%		-4.26%	-35.99%

07-09	MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue	MT
07-02	MicroPort Endovascular Expects Up to 30% Profit Growth in H1; Shares Rise 6%	MT

MicroPort Scientific Corporation acquired Conor Medsystems, LLC from Cordis Corporation.

January 20, 2014 at 04:00 am

MicroPort Scientific Corporation (SEHK:853) acquired Conor Medsystems, LLC from Cordis Corporation on January 20, 2014. In addition, MicroPort Scientific has entered into a non-exclusive license with Cordis for worldwide rights to certain of Cordis' DES patents and related intellectual property.

MicroPort Scientific Corporation (SEHK:853) completed the acquisition of Conor Medsystems, LLC from Cordis Corporation on January 20, 2014.

Latest news about MicroPort Scientific Corporation

MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue	07-09	MT
MicroPort Endovascular Expects Up to 30% Profit Growth in H1; Shares Rise 6%	07-02	MT
MicroPort Scientific Redeems $700 Million Convertible Bonds Ahead of 2026 Maturity	06-13	MT
Microport Scientific Corporation Announces Retirement of Non-Executive Directors	05-22	CI
MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth	05-01	MT
Nomura Adjusts MicroPort Scientific’s Price Target to HK$6.71 From HK$7.19, Keeps at Neutral	04-09	MT
MicroPort Scientific to Receive $150 Million Loan Facility, $300 Million Credit Support to Repay Convertible Bonds	04-08	MT
MicroPort Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Nomura Adjusts MicroPort Scientific’s Price Target to HK$7.19 From HK$17.59, Keeps at Neutral	03-06	MT
MicroPort Scientific Corporation Provides Earnings Guidance for the Year Ended 31 December 2023	03-05	CI
MicroPort Scientific Corporation Reports Revenue Results for the Twelve Months Ended 31 December 2023	03-05	CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit	01-30	MT
MicroPort Scientific Raises $220 Million from Convertible Bond Issue; To Buy Back, Cancel $217 Million of Existing Bonds	12-20	MT
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	12-18	MT
EV MedTech Raises 1.8 Billion Yuan from Placement	12-15	MT
MicroPort Scientific Says Businesses Maintain Steady Growth	12-11	MT
MicroPort Launches Tender Offer for Zero-Coupon Bonds Due 2026; To Issue New Debts Worth $220 Million	12-06	MT
MicroPort Scientific Names Dealer Managers for $700 Million Convertible Bond Buyback; Shares Plunge 19%	12-06	MT
Microport Neurotech Limited and Microport Scientific Corporation Agrees to Renew the 2022 Master Materials Procurement Agreement, the 2022 Master Supporting Services Procurement Agreement and the 2022 Master Catering Services Agreement	12-01	CI
MicroPort Scientific Corporation Announces Appointment of Peng Bo as Non-Executive Director and Member of the Strategic Committee	11-10	CI
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3	30/10/23	MT
Shanghai Microport MedBot Gets Thumbs Up to Launch Toumai Surgical Robot	26/10/23	MT
MicroPort Scientific's Loss Narrows in H1	31/08/23	MT
MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
MicroPort Scientific Corporation Announces Board Changes	30/08/23	CI

Chart MicroPort Scientific Corporation

Duration

Period

More charts

Company Profile

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Sector

Advanced Medical Equipment & Technology

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for MicroPort Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.6891 USD

Average target price

1.527 USD

Spread / Average Target

+121.61%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MICROPORT SCIENTIFIC CORPORATION	-35.99%	1.25B
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	187B
INTUITIVE SURGICAL, INC.	+26.34%	155B
BOSTON SCIENTIFIC CORPORATION	+33.90%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
AGILENT TECHNOLOGIES, INC.	-3.98%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.72B

Other Advanced Medical Equipment & Technology